Align Health Data Policy to Data Protection Bill to avoid overlaps: Experts
“It is worrying that the policy is being presented before the Personal Data Protection Bill has become legislation. This could create issues if there are differences in the policy and the version of the PDP bill that becomes an act,” said Shweta Mohandas, policy officer at the Centre for Interne t and Society. (Source: The Economic Times)
Source: The Economic Times - September 29, 2020 Category: Consumer Health News Source Type: news

India's Serum Institute to make an additional 100 million COVID-19 vaccine doses
The collaboration builds upon an initial agreement signed in August with the GAVI alliance and Gates Foundation, with the total number of vaccine doses to be covered by the partnership now up to 200 million. (Source: The Economic Times)
Source: The Economic Times - September 28, 2020 Category: Consumer Health News Source Type: news

One in 15 people aged 10 and above estimated to be exposed to SARS-CoV2 by Aug: ICMR sero survey
The second survey further showed that there is a lower infection to case ratio in August compared to May which reflects a substantial increase in testing and detection across India. (Source: The Economic Times)
Source: The Economic Times - September 28, 2020 Category: Consumer Health News Source Type: news

Don't agree with calculation of Rs 80k cr for COVID vaccine distribution in India: Health Ministry
Health Ministry Secretary Rajesh Bhushan was responding to a question tweeted by Serum Institute of India Chief Executive Officer Adar Poonawalla who asked the government whether it had Rs 80,000 crore over the next one year for distribution of COVID-19 vaccine. (Source: The Economic Times)
Source: The Economic Times - September 28, 2020 Category: Consumer Health News Source Type: news

Contact tracing no longer viable as pandemic rages on, say experts
With Covid-19 cases continuing to rise in Maharashtra and elsewhere in the country, bureaucrats and experts are questioning the viability of contact tracing, especially in areas where there is a high prevalence of infection, and calling for a rethink on the strategy. (Source: The Economic Times)
Source: The Economic Times - September 28, 2020 Category: Consumer Health News Source Type: news

FDA approved drug 'Teicoplanin' found more effective in treating COVID -19 virus: IIT Delhi research
The research by the institute's Kusuma School of Biological Science screened an assemblage of 23 approved drugs, which have shown leads towards being therapeutic options for coronavirus. (Source: The Economic Times)
Source: The Economic Times - September 27, 2020 Category: Consumer Health News Source Type: news

India's Feluda COVID-19 test cheaper, faster alternative to RT-PCR, say scientists
Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses even if genetic variations between them are minute. (Source: The Economic Times)
Source: The Economic Times - September 27, 2020 Category: Consumer Health News Source Type: news

Over five lakh PPEs being manufactured per day in India, says Health Minister Dr Harsh Vardhan
The Union Health Minister further said that India has conducted around 7 crore tests for COVID-19 and the recovery rate is improving. (Source: The Economic Times)
Source: The Economic Times - September 26, 2020 Category: Consumer Health News Source Type: news

View: Free market is great but not when a patient ’s survival depends on it
Although government hospitals have redeemed themselves to some extent in this pandemic by taking on most of the burden of care, they are still hamstrung by the lack of investment in basic facilities and staff. In one government hospital in Hyderabad, for instance, nurses used cut tree branches to hang intravenous bottles because there weren ’t enough IV poles around. (Source: The Economic Times)
Source: The Economic Times - September 26, 2020 Category: Consumer Health News Source Type: news

Medical tourism sector needs government support to get back on its feet: Sangita Reddy
"Medical value travel tourism is still nascent in India and holds great potential. Niti Aayog has identified medical value travel as one of the major growth drivers and a major source of forex earning," Apollo Hospitals Group Joint MD Sangita Reddy said. (Source: The Economic Times)
Source: The Economic Times - September 26, 2020 Category: Consumer Health News Source Type: news

NPPA caps price of liquid medical oxygen, medical oxygen cylinders
The Empowered Group 2 also requested NPPA to consider a cap for ex-factory price of oxygen in cylinders in order to ensure supply of oxygen cylinders from fillers at reasonable prices, the Ministry said. (Source: The Economic Times)
Source: The Economic Times - September 25, 2020 Category: Consumer Health News Source Type: news

Health ministry's 'eSanjeevani' records 4 lakh doctor-to-patient tele-consultations
The other states that have registered highest consultations through eSanjeevani and eSanjeevani OPD platforms are Himachal Pradesh (36,527), Kerala (33,340), Andhra Pradesh (31,034), Uttarakhand (11,526), Gujarat (8,914), Madhya Pradesh (8,904), Karnataka (7,684), and Maharashtra (7,103). (Source: The Economic Times)
Source: The Economic Times - September 25, 2020 Category: Consumer Health News Source Type: news

Post-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director
"Such issues get resolved in about six weeks in most cases. We advise them to exercise, have a diet with green leafy vegetables and multivitamins. But there is a small percentage who have serious damage. We have seen post-Covid fibrosis, wherein if you have pneumonia in your lungs, it leads to scarring of the lungs and the lungs do not recover." (Source: The Economic Times)
Source: The Economic Times - September 25, 2020 Category: Consumer Health News Source Type: news

Life after Covid: For survivors, reinfection and health complications are becoming causes for concern
At least a dozen recovered patients ET Magazine spoke to across the country complained of fatigue, memory lapses, inability to concentrate, loss of sense of smell or taste, shortness of breath and poor heart function. No one seems to be sure if and when the ailments would go away. (Source: The Economic Times)
Source: The Economic Times - September 25, 2020 Category: Consumer Health News Source Type: news

Mounting a fightback: Covid-19 vaccine developers reach last leg of trials
As US regulators tighten the scrutiny around approvals, companies have announced their intention to put their trial data in public domain for scientific enquiry to remove any doubt about safety and efficacy. (Source: The Economic Times)
Source: The Economic Times - September 25, 2020 Category: Consumer Health News Source Type: news

India tests record 15 Lakh people in a day, positivity rate falls to 5.8%
A total of 1,492,409 tests were conducted as of 8 am on Friday, according to data on the health ministry website. Cumulatively, over 6.89 million tests have been carried out, with the average per million at 49,948. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

National Medical Commission, India's regulator of medical education, comes into existence replacing MCI
With the NMC coming into being, the Board of Governors (BoG), which superseded the Medical Council of India (MCI) on September 26, 2018, to perform its functions, will get dissolved and the nearly 64-year-old Indian Medical Council Act will stand abolished. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

This is why Covid-19 could be life-threatening for some patients
“It looks like this virus has one big trick,” said Shane Crotty, a professor in the Center for Infectious Disease and Vaccine Research at the La Jolla Institute for Immunology in California. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

Some severe Covid-19 cases may be due to faulty genes, misguided antibodies, say scientists
The research, published in the journal Science, noted that both groups of patients lack type I interferon -- a set of 17 proteins crucial for protecting cells and the body from viruses. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

Nearly seven crore tests conducted in India for detection of COVID-19; positivity rate at 8.44%
This exponential surge in the daily testing capacities strongly demonstrates the determined escalation of the testing infrastructure in the country, the ministry said. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

Ayush Ministry to take up clinical study on potential of Vasa, Guduchi for management of COVID-19
This will be a randomized, open label three armed study, and will be conducted at the All India Institute of Ayurveda (AIIA), New Delhi, in collaboration with the IGIB unit of CSIR, the ministry said. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

Covid-19, dengue double infection treatment complicated; needs balanced approach: Experts
Delhi Deputy Chief Minister Manish Sisodia was shifted to LNJP Hospital on Wednesday for COVID-19 treatment and tested positive for dengue a day later. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

Supply delays, rise in Covid-19 cases lead to Remdesivir shortage
​​In India, companies such as Cipla, Dr Reddy’s, Hetero, Mylan, Zydus Cadila and Jubilant have the licence to manufacture the drug. Each of these companies is estimated to manufacture 100,000 vials every month. (Source: The Economic Times)
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

Primary healthcare focus area of government: Niti Aayog CEO Amitabh Kant
The Niti Aayog CEO also noted that the COVID-19 pandemic provides a unique opportunity to identify sectors which will become the next drivers of growth. (Source: The Economic Times)
Source: The Economic Times - September 23, 2020 Category: Consumer Health News Source Type: news

Government looks to review Tocilizumab inclusion for treatment, again
​​Tocilizumab,a rheumatoid arthritis drug, is part of the health ministry’s clinical management protocol for Covid-19 under investigational therapies for patients with moderate symptoms of the illness. (Source: The Economic Times)
Source: The Economic Times - September 23, 2020 Category: Consumer Health News Source Type: news

COVID anxiety waning, people okay with new norms: NIMHANS experts
Mental health experts at the National Institute of Mental Health and Neuro Sciences (Nimhans) have observed a 'positive sign of adaptation' among people to the new norm amid fears triggered by the Covid pandemic and an unprecedented countrywide lockdown that lasted for several weeks. (Source: The Economic Times)
Source: The Economic Times - September 23, 2020 Category: Consumer Health News Source Type: news

Six months since lockdown: Strides in testing, vaccine devt but COVID crisis far from over in India, say scientists
Six months on, India has the second highest number of cases in the world after the US with a tally of 57.32 lakh cases, 86,508 people testing positive in a day and a total of 91,149 fatalities, according to Union Health Ministry figures on Thursday. (Source: The Economic Times)
Source: The Economic Times - September 23, 2020 Category: Consumer Health News Source Type: news

COVID-19: Analysis reveals heart-related side effects of hydroxychloroquine, chloroquine
In the analysis of real-world data from the Food and Drug Administration Adverse Events Reporting System, a global database of post-marketing safety reports, hydroxychloroquine and chloroquine were associated with higher rates of various cardiovascular problems, including life-threatening heart rhythm events, heart failure, and damage to the heart muscle itself (termed cardiomyopathy). (Source: The Economic Times)
Source: The Economic Times - September 22, 2020 Category: Consumer Health News Source Type: news

India launches programme to strengthen clinical trial research capacity of vaccines in neighbouring countries
The training programme which will extend for about six to eight weeks will see participation of investigators, epidemiologists, clinicians and representatives from different departments from Nepal, Maldives, Bangladesh, Mauritius, Sri Lanka, Bhutan and Afghanistan. (Source: The Economic Times)
Source: The Economic Times - September 22, 2020 Category: Consumer Health News Source Type: news

COVID-19: Research on Mumbai doctors find reinfected patients have worse infection
Reinfection of Covid-19 has been confirmed using whole genome sequencing in four healthcare workers from Mumbai. All four have a more severe Covid-19 infection as compared to their earlier episode, according to a preprint published on The Lancet medical journal ’s website. Those reinfected include three doctors from Nair Hospital and a healthcare worker from Hinduja Hospital. (Source: The Economic Times)
Source: The Economic Times - September 22, 2020 Category: Consumer Health News Source Type: news

Coronavirus vaccine likely to be ready for India next year, says scientist
In India, Prime Minister Narendra Modi ’s government had promised an indigenous vaccine as early as mid-August, a claim the government and its apex medical research body has since walked back. (Source: The Economic Times)
Source: The Economic Times - September 21, 2020 Category: Consumer Health News Source Type: news

New probe that mimics coronavirus may speed up drug discovery, say scientists
The novel tool, described in the journal ACS Nano, is a fluorescent nanoparticle probe with the spike protein that is present on the surface of the SARS-CoV-2 virus, which it uses to bind to human cells and enter them. (Source: The Economic Times)
Source: The Economic Times - September 21, 2020 Category: Consumer Health News Source Type: news

Does the coronavirus spread easily among children?
​It appears the virus can spread among children and teens, but how easily may vary by age. Research is still underway, but children under age 10 seem to be less likely than older kids to transmit the virus to other children and adults. (Source: The Economic Times)
Source: The Economic Times - September 21, 2020 Category: Consumer Health News Source Type: news

Ayurvedic products less than 1 per cent of India's FMCG market: Kantar Worldpanel
The low sales contribution is despite more than a dozen leading companies flooding retail shelves with hundreds of natural and herbal variants over the past few years. While 89% of Indian households purchase ayurvedic products now compared to 76% four years ago, the entire segment contributes 0.8% of the total FMCG volume. (Source: The Economic Times)
Source: The Economic Times - September 21, 2020 Category: Consumer Health News Source Type: news

GenePath Diagnostics develops quantitative COVID-19 test kit for drug makers
The kit is currently being used by a couple of unidentified drug makers in India, said GenePath Diagnostics CEO Nickhil Jakatdar. He said this is the first quantitative test kit of its kind in India for Covid-19 and over time it could be used to test for other infectious diseases as well. (Source: The Economic Times)
Source: The Economic Times - September 21, 2020 Category: Consumer Health News Source Type: news

Daily recoveries from Covid-19 more than new infections reported per day for past four days: Govt
Addressing a press briefing, Union Health Ministry Secretary Rajesh Bhushan said India has the highest number of recovered cases in the world at 44,97,867. (Source: The Economic Times)
Source: The Economic Times - September 21, 2020 Category: Consumer Health News Source Type: news

Seven months into pandemic, finding a hospital bed is still tough in many places
A survey finds only 4% of people who needed an ICU bed were able to get it through routine process, 78% had to use connections; but as per official figures, there is no shortage. (Source: The Economic Times)
Source: The Economic Times - September 20, 2020 Category: Consumer Health News Source Type: news

To get approval in India, vaccines must work in at least 50% cases
​​ The vaccine that will go for approval must elicit superior immune responses compared to no vaccination against Covid-19, the guidelines said. An individual who gets the vaccine should be protected from reinfection for at least a year. (Source: The Economic Times)
Source: The Economic Times - September 20, 2020 Category: Consumer Health News Source Type: news

India ’s coronavirus vaccine pipeline could be one of the largest in the world
“Nationally, nearly 30 Covid-19 vaccine candidates are under development, by both industry and academia. These vaccines are in different stages of pre-clinical and clinical development,” said Harsh Vardhan, Union Minister for Health and Family Welfare, in the Lok Sabha last week. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Coronavirus prevalence was up to 55% in containment zones: Sero survey
Over 5,000 individuals were surveyed from 60 containment zones of 12 hotspot cities including Mumbai, Pune, Ahmedabad, Surat, Jaipur, Jodhpur, Agra, Southeast Delhi, Hyderabad, Indore, Chennai, Kolkata. Sources disclosed that the survey found that in containment zones 16.0% of the population has been exposed to the virus. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Electronic Vaccine Intelligence Network to track COVID-19 vaccine
A national expert group on COVID-19 vaccine has been constituted to guide the government on prioritisation of population groups for vaccination, selection of vaccine candidates, delivery mechanism of the vaccine, cold chain and associated infrastructure for roll-out of COVID-19 vaccination, etc. Minister of State for Health Ashwini Kumar Choubey said. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Covid grows less deadly as doctors gain practice, drugs improve
Public-health officials, epidemiologists, amateur observers and others have watched as the pandemic has unfolded, looking for how to measure the virus ’s deadliness. Tallying deaths as a percentage of the greater population sheds light on the scope of the pandemic. Excess mortality compares fatalities to what the death rate is expected to be. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

No significant mutation of coronavirus in India: Harsh Vardhan
Replying to queries during the 'Sunday Samvad' platform, Vardhan further said enough oxygen is being produced in the country and the health ministry is closely monitoring the situation. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

WCD, AYUSH ministries sign MoU for integration of AYUSH systems with ongoing nutrition interventions
The AYUSH Ministry will provide support to beneficiaries of the umbrella Integrated Child Development Services programme of the women and child development ministry, it said. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Three vaccine candidates in different stages of clinical trial: Harsh Vardhan
Replying to a discussion in Lok Sabha on the coronavirus pandemic, the Health Minister said there are 13,000 quarantine centres in the country with over 6 lakh beds. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Alchemy in the time of Covid: How a potential cure is the latter-day ‘elixir of life’
There are reportedly over 140 formulations currently undergoing trials at various levels. Governments and foundations have ploughed in billions to fund the search for a surefire ‘silver bullet,’ which will put paid once and for all to the dread virus that has overturned the world’s economic, social and political applecart. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

DCGI approves commercial launch of low cost Covid-19 test 'Feluda'
The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use. (Source: The Economic Times)
Source: The Economic Times - September 18, 2020 Category: Consumer Health News Source Type: news

Making a Covid vaccine is tough. So is shipping one at -80 degree Arctic temperatures
A number of the leading COVID-19 vaccines under development will need to be kept at temperatures as low as minus 80 degrees Celsius (minus 112 degrees Fahrenheit) from the moment they are bottled to the time they are ready to be injected into patients ’ arms. That will not be easy. (Source: The Economic Times)
Source: The Economic Times - September 18, 2020 Category: Consumer Health News Source Type: news

Fortis and Religare 'vehemently' oppose sale of trademarks in Delhi High Court
The court has been hearing a petition filed by Japanese drug firm Daiichi Sankyo seeking to attach and sell trademarks of Fortis and Religare and recover the amount due to it as per the Singapore tribunal arbitral award passed in April 2016. (Source: The Economic Times)
Source: The Economic Times - September 18, 2020 Category: Consumer Health News Source Type: news

E-certificates for people getting coronavirus vaccinations, says senior official
A government expert group on vaccines, which is looking into the procurement of Covid-19 vaccines — made in India and abroad — and the guiding principles for prioritisation of population groups for vaccination, has proposed setting up a digital platform to track procurement and record administration. (Source: The Economic Times)
Source: The Economic Times - September 18, 2020 Category: Consumer Health News Source Type: news